Synchrony Financial saw its IBD SmartSelect Composite Rating jump to 96 Tuesday, up from 94 the day before.
The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria. History shows the top market performers tend to have a 95 or higher score as they launch their major climbs.
Synchrony Financial is currently extended beyond a proper buy zone after clearing the 52.67 entry in a consolidation.
Discover The 3 Keys To Successful Stock Investing
The stock has an 88 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 88% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q3, the company reported 31% earnings growth. That means it's now delivered three straight quarters of rising EPS gains. Sales growth fell to 6%, down from 8% in the previous quarter.
Synchrony Financial holds the No. 3 rank among its peers in the Finance-Savings & Loans industry group. Axos Financial is the top-ranked stock within the group.
